Nuclear receptor-mediated alleviation of alcoholic fatty liver by polyphenols contained in alcoholic beverages

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Yao, Ruiqing ^a   Yasuoka, Akihito ^b,c   Kamei, Asuka ^c   Ushiama, Shota ^a   Kitagawa, Yoshinori ^d   Rogi, Tomohiro ^d   Shibata, Hiroshi ^d   Abe, Keiko ^a,c   Misaka, Takumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b MAEBASHI INSTITUTE OF TECHNOLOGY   (Japan)

^c KANAGAWA ACADEMY OF SCIENCE AND TECHNOLOGY   (Japan)

^d Suntory Wellness Limited Research Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; ELLAGIC ACID; POLYPHENOL; TETRAHYDROFOLIC ACID; TRANSCRIPTOME; UNSATURATED FATTY ACID; ALCOHOL; ANTIOXIDANT; CELL RECEPTOR; CENTRAL DEPRESSANT AGENT; RESVERATROL; STILBENE DERIVATIVE;

ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ALCOHOLIC FATTY LIVER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE ACID SYNTHESIS; CELL STRESS; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; FEMALE; GENE EXPRESSION PROFILING; MOUSE; NONHUMAN; STRESS; UPREGULATION; ANIMAL; C3H MOUSE; DEFICIENCY; DNA MICROARRAY; DRUG EFFECTS; FATTY LIVER, ALCOHOLIC; GENE ONTOLOGY; GENETICS; KNOCKOUT MOUSE; LIVER; METABOLISM;

ALCOHOLIC BEVERAGES; ANIMALS; ANTIOXIDANTS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ELLAGIC ACID; ETHANOL; FATTY LIVER, ALCOHOLIC; FEMALE; GENE ONTOLOGY; LIVER; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYPHENOLS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; STILBENES; TRANSCRIPTOME;

EID: 84895452013     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087142     Document Type: Article

References (60)

1. Crozier A, Jaganath IB, Clifford MN (2009) Dietary phenolics: chemistry, bioavailability effects on health. Nat Prod Rep 26: 1001-1043
2. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79: 727-747 (Pubitemid 41103873)
3. Opie LH, Lecour S (2007) The red wine hypothesis: from concepts to protective signalling molecules. Eur Heart J 28: 1683-1693 (Pubitemid 47227092)
4. Fujieda M, Tanaka T, Suwa Y, Koshimizu S, Kouno I (2008) Isolation and structure of whiskey polyphenols produced by oxidation of oak wood ellagitannins. J Agric Food Chem 56: 7305-7310
5. Arranz S, Chiva-Blanch G, Valderas-Martínez P, Medina-Remón A, Lamuela-Raventós RM, et al (2012) Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer. Nutrients 4: 759-781
6. Timmers S, Auwerx J, Schrauwen P (2012) The journey of resveratrol from yeast to human. Aging 4: 146-158
7. Larrosa M, García-Conesa MT, Espín JC, Tomás- Barberán FA (2010) Ellagitannins, ellagic acid and vascular health. Mol Aspects Med 31: 513-539
8. Devipriya N, Sudheer AR, Vishwanathan P, Menon VP (2008) Modulatory potential of ellagic acid, a natural plant polyphenol on altered lipid profile and lipid peroxidation status during alcohol-induced toxicity: a pathohistological study. J Biochem Mol Toxicol 22: 101-112 (Pubitemid 351657193)
9. Obara K, Mizutani M, Hitomi Y, Yajima H, Kondo K (2009) Isohumulones, the bitter component of beer, improve hyperglycemia and decrease body fat in Japanese subjects with prediabetes. Clin Nutr 28: 278-284
10. Yajima H, Noguchi T, Ikeshima E, Shiraki M, Kanaya T, et al. (2005) Prevention of diet-induced obesity by dietary isomerized hop extract containing isohumulones, in rodents. Int J Obes 29: 991-997 (Pubitemid 41076240)
11. Manzo-Avalos S, Saavedra-Molina A (2010) Cellular and mitochondrial effects of alcohol consumption. Int J Environ Res Public Health 7: 4281-4304
12. Purohit V, Gao B, Song BJ (2009) Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 33: 191-205
13. Sugamura K, Keaney JF Jr (2011) Reactive oxygen species in cardiovascular disease. Free Radic Biol Med 51: 978-992
14. Kelly GS (2010) A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 2. Altern Med Rev 15: 313-328
15. Park SJ, Ahmad F, Philp A, Baar K, Williams T, et al. (2012) Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148: 421-433
16. Shay NF, Banz WJ (2005) Regulation of gene transcription by botanicals: novel regulatory mechanisms. Annu Rev Nutr25, 297-315 (Pubitemid 41209004)
17. Sugden MC, Caton PW, Holness MJ (2010) PPAR control: it's SIRTainly as easy as PGC. J Endocrinol 204: 93-104
18. Penumetcha M, Santanam N (2012) Nutraceuticals as Ligands of PPARγ. PPAR Res 2012: 1-7
19. Sonoda J, Pei L, Evans RM (2008) Nuclear receptors: decoding metabolic disease. FEBS Lett 582: 2-9 (Pubitemid 350297241)
20. Caiozzi G, Wong BS, Ricketts ML (2012) Dietary modification of metabolic pathways via nuclear hormone receptors. Cell Biochem Funct 30: 531-551
21. Li L, Stanton JD, Tolson AH, Luo Y, Wang H (2009) Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways. Pharm Res 26: 872-882
22. Konno Y, Negishi M, Kodama S (2008) The roles of nuclear receptors CAR and PXR in hepatic energy metabolism. Drug Metab Pharmacokinet 23: 8-13
23. Yao R, Yasuoka A, Kamei A, Kitagawa Y, Rogi T, et al. (2011) Polyphenols in alcoholic beverages activating constitutive androstane receptor CAR. Biosci Biotechnol Biochem 75: 1635-1637
24. Yao R, Yasuoka A, Kamei A, Kitagawa Y, Tateishi N, et al. (2010) Dietary flavonoids activate the constitutive androstane receptor (CAR). J Agric Food Chem 58: 2168-2173
25. Seth D, Haber PS, Syn WK, Diehl AM, Day CP (2011) Pathogenesis of alcohol-induced liver disease: classical concepts and recent advances. J Gastroenterol Hepatol 26: 1089-1105
26. Altamirano J, Bataller R (2011) Alcoholic liver disease: pathogenesis and new targets for therapy. Nat Rev Gastroenterol Hepatol 8: 491-501
27. Park SH, Choi MS, Park TF (2007) Changes in the hepatic gene expression profile in a rat model of chronic ethanol treatment. Food Chem Toxicol 46: 1378-1388
28. Bardag-Gorce F, Oliva J, Dedes J, Li J, French BA, et al. (2009) Chronic ethanol feeding alters hepatocyte memory which is not altered by acute feeding. Alcohol Clin Exp Res 33: 684-692
29. Yin HQ, Je YT, Kim M, Kim JH, Kong G, et al. (2009) Analysis of hepatic gene expression during fatty liver change due to chronic ethanol administration in mice. Toxicol Appl Pharmacol 235: 312-320
30. Jiao X, Sherman BT, Huang da W, Stephens R, Baseler MW, et al. (2012) DAVID-WS: a stateful web service to facilitate gene/protein list analysis. Bioinformatics 28: 1805-1806
31. Breitling R, Armengaud P, Amtmann A, Herzyk P (2004) Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573: 83-92 (Pubitemid 39141040)
32. Stahl A (2003) A current review of fatty acid transport proteins (SLC27). Pflugers Arch 447: 722-727
33. Heuer H, Visser TJ (2009) Minireview: Pathophysiological importance of thyroid hormone transporters. Endocrinology 150: 1078-1083
34. Sato M, Mamada H, Anzai N, Shirasaka Y, Nakanishi T, et al. (2010) Renal secretion of uric acid by organic anion transporter 2 (OAT2/SLC22A7) in human. Biol Pharm Bull 33: 498-503
35. Corpe CP, Tu H, Eck P, Wang J, Faulhaber-Walter R, et al. (2010) Vitamin C transporter Slc23a1 links renal reabsorption, vitamin C tissue accumulation, and perinatal survival in mice. J Clin Invest 120: 1069-1083
36. Watkins PA, Ellis JM (2012) Peroxisomal acyl-CoA synthetases. Biochim Biophys Acta 1822: 1411-1420
37. Ferdinandusse S, Denis S, IJlst L, Dacremont G, Waterham HR, et al. (2000) Subcellular localization and physiological role of alpha-methylacyl-CoA racemase. J Lipid Res 41: 1890-1896
38. Ueda A, Hamadeh HK, Webb HK, Yamamoto Y, Sueyoshi T, et al. (2002) Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol Pharmacol 61: 1-6 (Pubitemid 34049505)
39. Rezen T, Tamasi V, Lövgren-Sandblom A, Björkhem I, Meyer UA, et al. (2009) Effect of CAR activation on selected metabolic pathways in normal and hyperlipidemic mouse livers. BMC Genomic 384: doi 10.1186/1471-2164-10-384.
40. Beilke LD, Aleksunes LM, Holland RD, Besselsen DG, Beger RD, et al. (2009) Constitutive androstane receptor-mediated changes in bile acid composition contributes to hepatoprotection from lithocholic acid-induced liver injury in mice. Drug Metab Dispos 37: 1035-1045
41. Tojima H, Kakizaki S, Yamazaki Y, Takizawa D, Horiguchi N, et al. (2012) Ligand dependent hepatic gene expression profiles of nuclear receptors CAR and PXR. Toxicol Lett 212: 288-297
42. Agius L (2008) Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J: 414, 1-18
43. Rubins NE, Friedman JR, Le PP, Zhang L, Brestelli J, et al. (2005) Transcriptional networks in the liver: hepatocyte nuclear factor 6 function is largely independent of Foxa2. Mol Cell Biol 25: 7069-7077 (Pubitemid 41105905)
44. Foufelle F, Ferré P (2002) New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem J 366: 377-391 (Pubitemid 35001682)
45. Cadoudal T, Distel E, Durant S, Fouque F, Blouin JM, et al. (2008) Pyruvate dehydrogenase kinase 4: regulation by thiazolidinediones and implication in glyceroneogenesis in adipose tissue. Diabetes 57: 2272-2279
46. Matsuzaka T, Shimano H (2009) Elovl6: a new player in fatty acid metabolism and insulin sensitivity. J Mol Med (Berl) 87: 379-384
47. Guillou H, Zadravec D, Martin PG, Jacobsson A (2010) The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice. Prog Lipid Res 49: 186-199
48. Song BJ, Moon KH, Olsson NU, Salem N Jr (2008) Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids. J Hepatol 49: 262-273
49. Schmitz G, Grandl M (2009) The molecular mechanisms of HDL and associated vesicular trafficking mechanisms to mediate cellular lipid homeostasis. Arterioscler Thromb Vasc Biol 29: 1718-1722
50. Wang Z, Yao T, Song Z (2009) Chronic alcohol consumption disrupted cholesterol homeostasis in rats: down-regulation of low-density lipoprotein receptor and enhancement of cholesterol biosynthesis pathway in the liver. Alcohol Clin Exp Res 34: 471-478
51. Brufau G, Groen AK, Kuipers F (2011) Reverse cholesterol transport revisited: contribution of biliary versus intestinal cholesterol excretion. Arterioscler. Thromb Vasc Biol 31: 1726-1733
52. Miranda-Mendez A, Lugo-Baruqui A, Armendariz-Borunda J (2010) Molecular basis and current treatment for alcoholic liver disease. Int. J. Environ. Res. Public Health 7: 1872-1888
53. Cederbaum AI (2010) Hepatoprotective effects of S-adenosyl-L-methionine against alcohol- and cytochrome P450 2E1-induced liver injury. World J Gastroenterol 16: 1366-1376
54. Mandrekar P (2011) Epigenetic regulation in alcoholic liver disease. World J Gastroenterol 17: 2456-2464
55. Bass J, Takahashi JS (2010) Circadian integration of metabolism and energetics. Science 330: 1349-1354
56. Spanagel R, Rosenwasser AM, Schumann G, Sarkar DK (2005) Alcohol consumption and the body's biological clock. Alcohol Clin Exp Res 29: 1550-1557 (Pubitemid 41243381)
57. Green CD, Han JD (2011) Epigenetic regulation by nuclear receptors. Epigenomics 3: 59-72
58. Kato S, Yokoyama A, Fujiki R (2011) Nuclear receptor coregulators merge transcriptional coregulation with epigenetic regulation. Trends Biochem Sci 36: 272-281
59. Gao J, He J, Zhai Y, Wada T, Xie W (2009) The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity. J Biol Chem 284: 25984-25992
60. Dong B, Saha PK, Huang W, Chen W, Abu-Elheiga LA, et al. (2009) Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc Natl Acad Sci U S A 106: 18831-18836.